Specifically binds to the VH3 sequence.
MabSelect VH3 affinity resin uses a protein A ligand designed to interact exclusively with the variable heavy chain of the human antibody VH3 sequence family. This allows for the efficient separation of fragments such as bispecific antibodies (bsAb), fragment antigen-binding regions (Fab), single-chain variable fragments (scFv), and variable heavy chain domains (VHH). • Interacts only with the variable heavy chain of VH3, not with the Fc region • High binding capacity for antibody fragments with VH3 • Removal of antibody-derived impurities from asymmetric bsAb with VH3 • Stable even after washing with 0.5 M NaOH
Inquire About This Product
basic information
For more details, please feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.